Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CSK Venture Capital was a prominent Japanese venture capital firm that specialized in early-stage investments within the life sciences and information technology sectors. As a subsidiary of the CSK Corporation, the firm played a pivotal role in fostering the Japanese biotechnology ecosystem during the late 1990s and 2000s. Its portfolio included several high-profile biotech companies such as Sosei, Acucela, and GNI Group. The firm provided not only financial capital but also strategic guidance to help startups navigate the transition from research to commercialization. Following the merger of CSK Corporation with Sumisho Computer Systems to form SCSK Corporation in 2011, the entity's independent operations were integrated into the broader corporate structure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CSK Venture Capital.